Key result
Colchicine resolves fever within 24 hours in a case of late-onset familial Mediterranean fever.
Why the study?
Late-onset familial Mediterranean fever is rare and often misdiagnosed due to symptoms mimicking other infectious or inflammatory diseases.
Case Report (n=1)
No
Late-onset Familial Mediterranean fever should be considered in older patients with unexplained recurrent serositis and pericarditis, as it responds rapidly to colchicine.
Late-onset FMF can present as recurrent pericarditis; leaves open whether genetic testing alters management in elderly patients.
Familial Mediterranean fever (FMF) is a rare genetic autoinflammatory disorder that usually appears in childhood. It is marked by recurrent episodes of fever and inflammation of the serous membranes. Late-onset cases are rare and often misdiagnosed due to symptoms similar to those of other infections or inflammatory diseases. We report the case of a 65-year-old man who presented with recurring fever, pleural effusions, and pericarditis over two months, suggestive of evolving constrictive physiology. Despite being hospitalized several times, tests for infections and cancers ruled out other causes. This included thoracenteses, a pericardial window, a pleural biopsy, and bone marrow analysis. Pathology showed fibrinous pericarditis and chronic pleuritis with fibrosis, without signs of cancer. The patient was started on colchicine, which led to a quick improvement in his condition. Considering the symptom presentation and response to colchicine, we diagnosed clinically probable FMF based on established criteria, noting that late-onset presentations over the age of 60 represent fewer than 5% of all FMF cases. This case emphasizes the need to suspect FMF in patients with unexplained recurrent serositis, even in older individuals. Although heart involvement in FMF is uncommon, it can imitate serious conditions and delay proper treatment. Colchicine is the main treatment, and regular follow-ups are important to check for response and side effects. A team approach is vital, especially in unusual cases, to lower the risk of complications such as amyloidosis and heart problems.
No takes yet. Share an insight, caveat, or question.
Govil et al. (2026) conducted a case report in Late-Onset Familial Mediterranean Fever (n=1). Colchicine was evaluated on Resolution of fever, dyspnea, and inflammatory markers. Colchicine 0.6 mg twice daily resulted in rapid resolution of fever within 24 hours and normalization of inflammatory markers in a 65-year-old male with late-onset familial Mediterranean fever.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: